Characterization of the novel Sezary lymphoma cell line <scp>BKP</scp>1
John Boudjarane, Régis Costello(Inserm), Thérèse Le Treut(Hôpital Nord), Nathalie Beaufils(Hôpital Nord), Yaël Berda‐Haddad(Assistance Publique Hôpitaux de Marseille), Romaric Lacroix(Inserm), Cornel Popovici(Inserm), Mårina Lafage‐Pochitaloff(Inserm), Corinne Nicolino‐Brunet(Hôpital de la Conception), Laure Farnault(Aix-Marseille Université), Hélène Zattara(Aix-Marseille Université), Brigitte Kahn‐Perlès(Inserm), Jean Gabert(Hôpital Nord), Arnaud Essaydi(Hôpital Nord)
Cited by 2
Related Papers
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547
MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments
|Journal of Extracellular Vesicles|2020|514